Anne Goldfeld bridges research and action in global health
Anne Goldfeld, M.D., was interviewed Friday morning February 1st by WBUR radio Host of 'Morning Edition' Bob Oakes. She was recognized in their 'Visionary Series' as someone who "bridges research and action in global health". Dr. Goldfeld is an HMS Professor of Medicine and Senior Investigator in the Program in Cellular and Molecular Medicine at BCH who is active in both Cambodia and Ethiopia working to treat and prevent the spread of tuberculosis and AIDs. To see the written article and hear the WBUR broadcast click here.
(image at right) Dr. Anne Goldfeld with Dr. Johannes who was treated by Goldfeld's team for the drug-resistant TB he acquired from a patient while in medical school. Now cured and graduated, he is a doctor in the drug resistant TB ward at Gondar University Hospital that Goldfeld and colleagues established.
Founded in 1953, the Program in Molecular and Cellular Medicine and the Immune Disease Institute (PCMM/IDI) is a non-profit research institution in Boston, MA, recognized worldwide for its discoveries that increase the body's ability to fight disease and to heal. With the aim of increasing collaborations and scientific synergies, Immune Disease Institute and Children’s Hospital Boston have entered into an affiliation whereby IDI joins seven other interdisciplinary programs as the Program in Cellular and Molecular Medicine. PCMM/IDI is also academically affiliated with Harvard Medical School, and its investigators hold appointments in departments of the medical school.
The breakthroughs of PCMM/IDI scientists are greatly increasing our understanding of the influence of immune defense and inflammation on biomedical discovery, healthcare, and disease management. Visit About Us to learn more.